A national survey of medical staffs' required capability and workload for accelerator-based boron neutron capture therapy.

accelerator-based BNCT boron neutron capture therapy (BNCT) capability specialized procedure workload

Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
22 Aug 2024
Historique:
received: 04 03 2024
revised: 03 05 2024
medline: 21 8 2024
pubmed: 21 8 2024
entrez: 21 8 2024
Statut: aheadofprint

Résumé

This study aimed to identify the required capabilities and workload of medical staff in accelerator-based boron neutron capture therapy (BNCT). From August to September 2022, a questionnaire related to the capabilities and workload in the accelerator-based BNCT was administered to 12 physicians, 7 medical physicists and 7 radiological technologists engaged in BNCT and 6 other medical physicists who were not engaged in BNCT to compare the results acquired by those engaged in BNCT. Only 6-21% of patients referred for BNCT received it. Furthermore, 30-75% of patients who received BNCT were treated at facilities located within their local district. The median required workload per treatment was 55 h. Considering additional workloads for ineligible patients, the required workload reached ~1.2 times longer than those for only eligible patients' treatment. With respect to capabilities, discrepancies were observed in treatment planning, quality assurance and quality control, and commissioning between medical physicists and radiological technologists. Furthermore, the specialized skills required by medical physicists are impossible to acquire from the experience of conventional radiotherapies as physicians engaged in BNCT were specialized not only in radiation oncology, but also in other fields. This study indicated the required workload and staff capabilities for conducting accelerator-based BNCT considering actual clinical conditions. The workload required for BNCT depends on the occupation. It is necessary to establish an educational program and certification system for the skills required to safely and effectively provide BNCT to patients.

Identifiants

pubmed: 39167773
pii: 7738318
doi: 10.1093/jrr/rrae058
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Health, Labour and Welfare for Health Sciences Research
ID : 23EA1012
Organisme : Japan Society for the Promotion of Science London
ID : 19K17218
Organisme : Japan Agency for Medical Research and Development
ID : 23mk0121267h0001

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Auteurs

Satoshi Nakamura (S)

Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Division of Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita City, Osaka 565-0871, Japan.

Hiroki Tanaka (H)

Particle Radiation Oncology Research Center, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2-1010 Asashiro-Nishi, Kumatori-cho, Sennan-gun, Osaka 590-0494, Japan.

Takahiro Kato (T)

Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakae-machi, Fukushima City, Fukushima 960-8516, Japan.
Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center 7-10 Yatsuyamada, Koriyama, Fukushima 963-8052, Japan.

Kazuhiko Akita (K)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan.

Mihiro Takemori (M)

Division of Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Department of Radiation Oncology, National Cancer Center Hospital 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Department of Radiology and Radiation Oncology, Edogawa Hospital, 2-24-18 Hgashikoiwa, Edogawa-ku, Tokyo 133-0052, Japan.

Yusaku Kasai (Y)

Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita City, Osaka 565-0871, Japan.
Department of Radiological Technology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Tairo Kashihara (T)

Division of Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Department of Radiation Oncology, National Cancer Center Hospital 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Yoshihiro Takai (Y)

Department of Radiation Oncology, Southern Tohoku BNCT Research Center, 7-10 Yatsuyamada, Koriyama, Fukushima 963-8052, Japan.

Keiji Nihei (K)

Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan.
Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan.

Hiroshi Onishi (H)

Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan.

Hiroshi Igaki (H)

Division of Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Department of Radiation Oncology, National Cancer Center Hospital 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Classifications MeSH